{"id":267,"date":"2020-12-07T18:03:03","date_gmt":"2020-12-07T22:03:03","guid":{"rendered":"http:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=267"},"modified":"2020-12-07T18:03:03","modified_gmt":"2020-12-07T22:03:03","slug":"pbms-must-say-goodbye-to-manufacturer-rebates","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2020\/12\/07\/pbms-must-say-goodbye-to-manufacturer-rebates\/","title":{"rendered":"PBMs Must Say Goodbye to Manufacturer Rebates"},"content":{"rendered":"

Pharmacy benefit managers (PBMs) play a significant role in U.S. drug pricing, yet their existence is little known to those outside of the pharmaceutical and insurance arenas. In an effort to modify one of the largest drivers in increasing drug costs\u2015rebates paid to PBMs by drug manufacturers\u2015the U.S. Department of Health and Human Services on November 20, 2020, published three final rules that, most notably, declared that these rebates are no longer protected by the safe harbors to the anti-kickback statute.<\/p>\n

To read the full text of this Duane Morris Alert<\/em>, please visit the firm website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmacy benefit managers (PBMs) play a significant role in U.S. drug pricing, yet their existence is little known to those outside of the pharmaceutical and insurance arenas. In an effort to modify one of the largest drivers in increasing drug costs\u2015rebates paid to PBMs by drug manufacturers\u2015the U.S. Department of Health and Human Services on … <\/p>\n

Continue reading “PBMs Must Say Goodbye to Manufacturer Rebates”<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[513,516,509,511,26,515,514,508,77,507,510,512,471],"ppma_author":[521],"class_list":["post-267","post","type-post","status-publish","format-standard","hentry","category-general","tag-anti-kickback-statute","tag-bradley-wasser","tag-drug-pricing","tag-final-rules","tag-hhs","tag-jonathan-swichar","tag-kickbacks","tag-pbms","tag-pharmaceutical","tag-pharmacy-benefit-managers","tag-rebates","tag-safe-harbors","tag-u-s-department-of-health-and-human-services"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=267"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/267\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=267"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}